These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37536118)

  • 1. A beneficial role of GLP-1 receptor agonist therapy in ABCC8-MODY (MODY 12).
    Nakhleh A; Goldenberg-Furmanov M; Goldstein R; Shohat M; Shehadeh N
    J Diabetes Complications; 2023 Sep; 37(9):108566. PubMed ID: 37536118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterozygous ABCC8 mutations are a cause of MODY.
    Bowman P; Flanagan SE; Edghill EL; Damhuis A; Shepherd MH; Paisey R; Hattersley AT; Ellard S
    Diabetologia; 2012 Jan; 55(1):123-7. PubMed ID: 21989597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment.
    Song J; Yang Y; Mauvais-Jarvis F; Wang YP; Niu T
    BMC Med Genet; 2017 Jun; 18(1):64. PubMed ID: 28587604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Elusive Nature of ABCC8-related Maturity-Onset Diabetes of the Young (ABCC8-MODY). A Review of the Literature and Case Discussion.
    Marassi M; Morieri ML; Sanga V; Ceolotto G; Avogaro A; Fadini GP
    Curr Diab Rep; 2024 Sep; 24(9):197-206. PubMed ID: 38980630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of K
    Ngoc CTB; Dien TM; De Franco E; Ellard S; Houghton JAL; Lan NN; Thao BP; Khanh NN; Flanagan SE; Craig ME; Dung VC
    Front Endocrinol (Lausanne); 2021; 12():727083. PubMed ID: 34566892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rare mutation in ABCC8/SUR1 leading to altered ATP-sensitive K+ channel activity and beta-cell glucose sensing is associated with type 2 diabetes in adults.
    Tarasov AI; Nicolson TJ; Riveline JP; Taneja TK; Baldwin SA; Baldwin JM; Charpentier G; Gautier JF; Froguel P; Vaxillaire M; Rutter GA
    Diabetes; 2008 Jun; 57(6):1595-604. PubMed ID: 18346985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype, genotype and glycaemic variability in people with activating mutations in the ABCC8 gene: response to appropriate therapy.
    Reilly F; Sanchez-Lechuga B; Clinton S; Crowe G; Burke M; Ng N; Colclough K; Byrne MM
    Diabet Med; 2020 May; 37(5):876-884. PubMed ID: 31562829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1alpha genes.
    Elbein SC; Sun J; Scroggin E; Teng K; Hasstedt SJ
    Diabetes Care; 2001 Mar; 24(3):472-8. PubMed ID: 11289470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCC8-related maturity-onset diabetes of the young: switching from insulin to sulphonylurea therapy: how long do we need for a good metabolic control?
    Evin F; Işık E; Onay H; Özen S; Darcan Ş; Gökşen D
    J Pediatr Endocrinol Metab; 2023 Jun; 36(6):592-597. PubMed ID: 37071846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of ABCC8 as a contributory gene to impaired early-phase insulin secretion in NZO mice.
    Andrikopoulos S; Fam BC; Holdsworth A; Visinoni S; Ruan Z; Stathopoulos M; Thorburn AW; Joannides CN; Cancilla M; Balmer L; Proietto J; Morahan G
    J Endocrinol; 2016 Jan; 228(1):61-73. PubMed ID: 26493453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of activating mutations in the sulfonylurea receptor 1 (ABCC8) causing neonatal diabetes mellitus in Asian Indian children.
    Balamurugan K; Kavitha B; Yang Z; Mohan V; Radha V; Shyng SL
    Pediatr Diabetes; 2019 Jun; 20(4):397-407. PubMed ID: 30861254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Report: A Novel
    Tang C; Meng L; Zhang P; Liang X; Dang C; Liang H; Wu J; Lan H; Qin Y
    Front Endocrinol (Lausanne); 2021; 12():758723. PubMed ID: 35002955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Correction of Trafficking Defects in ATP-sensitive Potassium Channels Caused by Sulfonylurea Receptor 1 Mutations.
    Martin GM; Rex EA; Devaraneni P; Denton JS; Boodhansingh KE; DeLeon DD; Stanley CA; Shyng SL
    J Biol Chem; 2016 Oct; 291(42):21971-21983. PubMed ID: 27573238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentation and long-term outcome of patients with KCNJ11/ABCC8 variants: Neonatal diabetes or MODY in the DPV registry from Germany and Austria.
    Warncke K; Eckert A; Kapellen T; Kummer S; Raile K; Dunstheimer D; Grulich-Henn J; Woelfle J; Wenzel S; Hofer SE; Dost A; Holl RW
    Pediatr Diabetes; 2022 Nov; 23(7):999-1008. PubMed ID: 35822653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of type 2 diabetes mellitus and other specific types of diabetes; its role in treatment modalities.
    Kota SK; Meher LK; Jammula S; Kota SK; Modi KD
    Diabetes Metab Syndr; 2012; 6(1):54-8. PubMed ID: 23014256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 inhibits pancreatic ATP-sensitive potassium channels via a protein kinase A- and ADP-dependent mechanism.
    Light PE; Manning Fox JE; Riedel MJ; Wheeler MB
    Mol Endocrinol; 2002 Sep; 16(9):2135-44. PubMed ID: 12198249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.
    Babenko AP; Polak M; Cavé H; Busiah K; Czernichow P; Scharfmann R; Bryan J; Aguilar-Bryan L; Vaxillaire M; Froguel P
    N Engl J Med; 2006 Aug; 355(5):456-66. PubMed ID: 16885549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Searching for Maturity-Onset Diabetes of the Young (MODY): When and What for?
    Timsit J; Saint-Martin C; Dubois-Laforgue D; Bellanné-Chantelot C
    Can J Diabetes; 2016 Oct; 40(5):455-461. PubMed ID: 27103109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into K
    Pipatpolkai T; Usher S; Stansfeld PJ; Ashcroft FM
    Nat Rev Endocrinol; 2020 Jul; 16(7):378-393. PubMed ID: 32376986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes in very young children and mutations in the insulin-secreting cell potassium channel genes: therapeutic consequences.
    Flechtner I; Vaxillaire M; Cavé H; Scharfmann R; Froguel P; Polak M
    Endocr Dev; 2007; 12():86-98. PubMed ID: 17923772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.